UK Advertising Watchdog Cracks Down on False Health Claims for Autism, ADHD, and Prostate Cancer
Table of Contents
The UK’s Advertising Standards Authority (ASA) has taken decisive action against misleading online advertisements promoting unproven treatments and diagnostic tools for serious health conditions, including autism, ADHD, and prostate cancer. The regulator issued enforcement notices and banned advertisements for 11 different supplements and tests on Wednesday, signaling a growing concern over the proliferation of dubious health products online.
The ASA’s intervention highlights the vulnerability of individuals seeking information and solutions for complex health concerns, and the challenges of regulating the rapidly evolving digital advertising landscape.The banned advertisements made “misleading claims” that risked “steering those who need it away from appropriate medical advice,” according to a statement released by the agency.
Targeting Vulnerable Populations
Several of the advertisements specifically targeted parents of children with autism, offering supplements promising benefits such as “[f]ewer meltdowns. More energy & alertness. Even trying NEW foods!” Retailer EllaOla faced criticism for this ad, while Israeli-based nutrition clinic Customized Autism Treatment was reprimanded for promoting “Autism Recovery Supplements.” These claims are particularly concerning, as autism and ADHD are recognized as neurodevelopmental conditions, not illnesses with cures.
Another advertisement pitched supplements as “the perfect gift for anyone with ADHD,” and a separate product claimed consumers could “Skip The Doctors With a Rapid Prostate Home Test Kit.” the accuracy and safety of such at-home prostate tests remain “not proven,” warned the Prostate Cancer UK charity, which recommends seeking diagnosis through a qualified healthcare professional.
AI and Increased Scrutiny
The ASA is increasingly utilizing artificial intelligence (AI) to monitor the vast number of online advertisements – tens of millions annually – and identify potentially misleading health claims. “We are keeping a close eye on health claims in online ads,” said Jess Tye,regulatory project manager at the ASA. “The ASA prioritises protecting vulnerable peopel and we recognize when it comes to health concerns people can be particularly vulnerable.”
The regulator’s action underscores a broader trend: rules and enforcement often struggle to keep pace with companies making unproven promises of improved health and longevity. The surge in ADHD diagnoses in the UK, prompting a review announced last week by health secretary wes Streeting, has coincided with a rise in related advertising, further emphasizing the need for vigilance.
expanding Investigations and Future Priorities
Beyond the current enforcement actions, the ASA is actively investigating advertisements targeting menopause and women’s hormonal health, designating it a “priority” area. The regulator maintains strict rules regarding medicinal claims made by products that are not licensed medicines, and a publicly available list of authorized health claims requiring supporting evidence.Medical claims for food products are explicitly prohibited.
Several companies involved in the misleading advertising have responded to the ASA’s rulings. Customized Autism Treatment claimed the ad in question was generated unintentionally by an automated online program. EllaOla has discontinued the problematic advertisement, and Get Dopa, the supplement brand behind a censured ADHD ad, stated it has updated its advertising to comply with the ASA’s decision.
The ASA’s ongoing efforts demonstrate a commitment to protecting consumers from false and potentially h
